Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dotinurad Urate-Lowering Therapy at Different Time Windows for Gout
NCT07661030Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jul 2026
- Primary completion
- Jul 2027
01
Overview
Phase 4, randomised trial of dotinurad in gout (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Days to resolution of an acute gout flare at 12 weeks. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dotinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT07661030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07661030.